Abbisko Therapeutics Announced the Entry into a Licensing Ag

SHANGHAI, Dec. 4, 2023 /PRNewswire/ -- On 4 Dec. 2023, Abbisko Therapeutics announced that it has entered into a licensing agreement with Merck, a leading science and technology company...

Related Keywords

Shanghai , China , Canada , Hong Kong , Germany , Macau , Taiwan , United States , Chinese , Xu Yao Chang , Andrew Paterson , Hong Kong Stock Exchange , Abbisko Therapeutics Co Ltd , Abbisko Cayman Limited Stock Code , Abbisko Therapeutics , License Agreement , Global Commercialization Option , Chief Marketing Officer , Priority Medicine , Risk Evaluation , Mitigation Strategy , Abbisko Cayman Limited , Stock Code , Markets ,